Parataxis Holdings LLC has entered right into a definitive settlement to amass a controlling curiosity in South Korean biotech firm Bridge Biotherapeutics, Inc. (KOSDAQ: 288330) for KRW 25 billion ($18.3 million), marking the creation of South Korea’s first institutionally backed Bitcoin treasury firm.
The transaction will see Bridge Biotherapeutics renamed to Parataxis Korea and proceed buying and selling on the KOSDAQ change, topic to shareholder approval and customary closing circumstances. The deal represents a major pivot for the medical stage biotech firm, which has been growing therapeutics for ulcerative colitis, fibrotic ailments, and cancers since its 2015 founding.
Edward Chin, Founder and CEO of Parataxis Holdings and Co-Founder & CEO of Parataxis Capital, will be a part of Bridge Bio’s Board of Administrators following the transaction’s completion. Andrew Kim, Companion at Parataxis Capital, will assume the CEO position and in addition be a part of the board, whereas Bridge Bio co-founder James Jungkue Lee will proceed main the core biotech enterprise.
“Impressed by the rising curiosity in BTC treasury methods seen in corporations like Technique within the US and Metaplanet in Japan, we imagine institutional curiosity on this area is rising globally,” stated Andrew Kim. “We see South Korea as an vital market within the evolution of BTC adoption. Our intent is to help institutional entry to BTC publicity whereas emphasizing sound company governance and disciplined capital administration.”
The acquisition transforms Bridge Biotherapeutics from a conventional biotech operation right into a hybrid entity that may keep its present therapeutic growth packages whereas establishing a Bitcoin treasury. South Korea’s market and rising institutional adoption might make it a beautiful jurisdiction for such ventures, significantly as regulatory frameworks proceed to mature within the area.
Edward Chin emphasised the strategic nature of the funding, stating: “We’re extremely excited to create the primary BTC treasury firm in South Korea backed by an institutional-grade platform. Given the strategic nature of BTC on the worldwide stage and its finite provide, we imagine that constructing and rising an organization like Parataxis Korea and accumulating a BTC treasury will profit our shareholders in addition to the nation over the long term.”
The transaction is anticipated to shut following shareholder approval at a gathering scheduled for August, with Shin & Kim LLC and Deloitte serving as authorized and monetary advisors.
